Early vs. Late Time Restricted Eating in Adolescents With Obesity at Risk for Diabetes
Study Details
Study Description
Brief Summary
Many adolescents find it challenging to adhere to conventional treatment for pediatric obesity because they require daily calorie counting, easy access to fresh food, and the ability to change the home environment. As such, adherence is poor which limits efficacy. One simpler and promising approach is limiting the timing of eating, instead of changing the food quality or quantity. This approach is called, Time-restricted eating (TRE) and involves eating over an 8- to 10-hour eating window and fasting for the remainder of the day.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
In adults, there is growing evidence that early TRE is more effective in improving metabolic outcomes than other forms of TRE, however it is unclear whether adolescents will be able to adhere to such recommendations. Hence, in the present study we propose a 24-week, 2-arm, parallel randomized pilot trial in 100 adolescents (age 13-18 years, all gender expressions, anticipate 65% Latino) with obesity, to test the preliminary efficacy of early vs. late TRE on glycemic profiles, weight loss, and body composition. We hypothesize that, among adolescents who can adhere to the meal timing recommendations, early TRE will result in greater improvement in metabolic endpoints than late TRE. We will test the hypothesis with 3 specific aims: Aim 1: Test the effect of early vs. late TRE on glycemic profiles and β-cell function. Aim 2: Test the effect of early vs. late TRE on obesity and body composition, and cardiometabolic risk factors. Aim 3: Test the effect of early vs. late TRE on exploratory outcomes including sleep, physical activity, and dietary intake to explore how meal timing may influence occurrence, timing, and distribution of sleep and movement as well as dietary intake and caloric distribution. This study is the first study evaluating the effectiveness of early vs. late TRE in adolescents with obesity at risk for diabetes.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Early Time Restricted Eating early-day TRE (7:00 to 15:00 h) |
Behavioral: Early Time Restricted Eating
Early Time Restricted Eating 7 AM to 3 PM
|
| Experimental: Late Time Restricted Eating late TRE (12:00 to 20:00 h) |
Behavioral: Late Time Restricted Eating
Late Time Restricted Eating 12 PM to 8 PM
|
Outcome Measures
Primary Outcome Measures
- Mean change in weight in excess of the 95th percentile at week 24 compared to baseline [week 24]
Change in weight in excess of the 95th percentile
Secondary Outcome Measures
- Mean change in total body fat mass as measured on DEXA scan at week 24 compared to baseline [week 24]
Change in total body fat mass measured on DEXA scan
- Mean change in percent time in range as captured on contiguous glucose monitor at week 24 compared to baseline [week 24]
%TIR captured on CGM
- Mean change in hemoglobin A1c at week 24 compared to baseline [week 24]
HgA1c measured at baseline and week 24
- Mean change in ALT at week 24 compared to baseline [week 24]
ALT measured at baseline and week 24
- Mean change in systolic and diastolic blood pressure at week 24 compared to baseline [week 24]
Measured systolic and diastolic blood pressure at baseline and week 24
Eligibility Criteria
Criteria
Inclusion Criteria:
-
12-21 years with obesity (BMI>95th percentile)
-
participant must be willing and able to adhere to the assessments, visit schedules, and eating/fasting periods
-
baseline eating window greater than 12 hours.
Exclusion Criteria:
-
diagnosis of Prader-Willi Syndrome, brain tumor, or diabetes serious intellectual disability
-
previous diagnosis or subthreshold symptoms of an eating disorder (anorexia nervosa, bulimia nervosa, binge-eating disorder)
-
parent/guardian-reported physical, mental of other inability to participate in the assessments
-
previous bariatric surgery
-
current participation in other interventional weight loss studies.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Children's Hospital Los Angeles
Investigators
- Principal Investigator: Alaina Vidmar, MD, Children's Hospital Los Angeles
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CHLA-22-00395